精确准STING:癌症治疗的挑战,创新和临床前景
Jiaqi Shi1,2, Yingying Zhang2,3, Na Zhao2,3
1Department of Phase I Trials Center, Harbin Medical University Cancer Hospital, 150 Haping Road, Nangang District, Harbin 150081, P.R. China.
Innovation (Cambridge (Mass.))
|February 25, 2026
概括
对于用于癌症治疗的STING激动剂的临床试验,由于生物和耐药性障碍,其成功程度有限. 需要新的策略,包括精准医学和组合疗法,以改善STING通路激活和增强抗癌疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 干扰素基因刺激 (STING) 途径对免疫反应至关重要,也是有希望的癌症治疗点.
- 对STING激动剂的临床试验已经产生了有限的持久疗效,未能进入第三阶段.
- 了解抵抗机制是改善基于STING的癌症治疗的关键.
研究的目的:
- 审查在癌症治疗中阻碍STING通路激活的生物,药理和临床障碍.
- 探索与宿主相关的和获得的抵抗机制,限制STING激动剂的疗效.
- 在瘤学中确定优化STING通路激活的新策略.
主要方法:
- 对癌症中STING激动剂的临床前和临床研究的文献综述.
- 分析与STING通路功能和耐药性相关的生物学,药理学和临床数据.
- 综合药物输送,小分子设计和组合疗法的最新进展.
主要成果:
- 刺痛激动剂和宿主耐药性的固有局限性 (瘤异质性,免疫抑制) 阻碍了疗效.
- 获得的抵抗机制包括免疫检查点上调和效应免疫细胞抑制.
- 交付平台,药物设计和组合策略的进步提供了潜在的解决方案.
结论:
- 精细的,特定于环境的STING激活策略对于释放治疗潜力至关重要.
- 精确的方法,包括准人类STING变体和生物标志物驱动的分层,是有希望的.
- 克服耐药性和优化STING通路调节对于成功的癌症免疫治疗至关重要.
更多相关视频
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K


